The new facility, made via foreign direct investment, will be located in
the GMR Aerospace Park at the Rajiv Gandhi International Airport
approximately 25 kilometers south of Hyderabad city center.
Approximately 4,000 square meters in size, the facility will house
Multisorb's state-of-the-art manufacturing processes in a clean room
environment. As with all Multisorb manufacturing sites, it will be
compliant to the United States FDA's CGMP standards (21 CFR Parts
210-211).
"Our investment in India reflects Multisorb's continuing commitment to
Indian pharmaceutical manufacturers", said Eric Armenat, CEO of Multisorb
Technologies. "We're very pleased to take our relationship with our
customers to the next level via local manufacturing and participating in
Make in India program", Armenat added.
Laxmikant Khaitan, General Manager of Multisorb Technologies India Pvt.
Ltd., will lead the new Hyderabad site.
"Multisorb's advanced sorbent and complementary dispensing technologies
have become the industry standard in India over the past 15 years. Our
customers will now enjoy these technologies at a lower landed cost",
stated Khaitan.
"India has been a global pharmaceutical manufacturing center for a number
of years", advised Multisorb's Adrian Possumato, Vice President of
Healthcare Packaging. "We are pleased to expand our role in India by
joining the local manufacturing community and supporting our Success
through Efficiency(sm) program directly from our Hyderabad site", added
Possumato.
Multisorb plans to manufacture its DMF-supported products in its
Hyderabad facility including StripPax(®) desiccant/sorbent packets,
IntelliSorb(®) moisture regulating packets, and StabilOx(®) oxygen
absorbing packets. It expects to host customer quality system audits of
the site during Q4-2017 and begin supplying Indian customers from the
Hyderabad site in early Q1-2018.
